Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 19, 2004

View Archived Issues

Promising atypical antipsychotic agent by Sigma-Tau

Sesame oil shows beneficial effects in hypertensive patients

Bispecific antibody targets EGFR-positive bile duct carcinoma

Promising nonpeptide galanin receptor agonist for treatment of epilepsy, depression and pain

Phytoestrogen shows vasodilating effects in vitro

MediGene acquires anticancer drugs and technology of Munich Biotech

Methanobactin: a novel peptide with antioxidant and antibiotic properties

Pfizer scientists describe new antiangiogenic agents for ocular disorders

New PI3K inhibitors and their use claimed by Pfizer

Novel PDE4 inhibitors discovered by Zambon researchers

Dual angiotensin/endothelin antagonists prepared and tested at Kyowa Hakko

Novel allosteric modulators of muscarinic receptors for psoriasis and other disorders

Vernalis presents new antibacterial agents in a recent patent

Preliminary phase II results for XMP-629

Chiron to produce pandemic-like influenza vaccines for NIAID testing

Replidyne obtains rights to faropenem daloxate

Nabi completes milestones in StaphVAX development

Chronic toxicity study completed for MDI-P

Fast track status for temsirolimus for first-line treatment of advanced RCC

Canadian approval for Tiazac XC

Priority review for new 500-mg formulation of Invirase

Paradigm Genetics changes name to Icoria

Antegren submitted for approval in Canada

Genzyme makes important progress during second quarter

Endo highlights recent developments

Nippon Shinyaku presents novel potent non-prostanoid prostacyclin agonist

Novel non-competitive AMPA antagonist shows potent neuroprotective activity in vivo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...